1,629
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Enhancement of curcumin antitumor efficacy and further photothermal ablation of tumor growth by single-walled carbon nanotubes delivery system in vivo

, , , , &
Pages 1017-1026 | Received 22 Aug 2019, Accepted 23 Sep 2019, Published online: 03 Oct 2019

References

  • Al Fatease A, Shah V, Nguyen DX, et al. (2019). Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer. Nanomed-Nanotechnol 19:39–48.
  • Aqil F, Munagala R, Jeyabalan J, Vadhanam MV. (2013). Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett 334:133–41.
  • Blanco E, Sangai T, Hsiao A, et al. (2013). Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment. Cancer Lett 334:245–52.
  • Chen D, Gong FR, Han XX, et al. (2019). Preparation and characterization of glutathione-responsive polymeric micelles functionalized with core cross-linked disulfide linkage for curcumin delivery. J Polym Res 26:103.
  • Du B, Han S, Li H, et al. (2015). Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy. Nanoscale 7:5411–26.
  • El Khoury D, Matar R, Touma T. (2019). Curcumin and endometrial carcinoma: an old spice as a novel agent. Int J Woman’s Health 11:249–56.
  • Forouzanfar F, Barreto G, Majeed M, Sahebkar A. (2019). Modulatory effects of curcumin on heat shock proteins in cancer: a promising therapeutic approach. BioFactors. doi:https://doi.org/10.1002/biof.1522.
  • Jamwal R. (2018). Bioavailable curcumin formulations: a review of pharmacokinetic studies in healthy volunteers. J Integr Med 16:367–74.
  • Kanai M, Yoshimura K, Asada M, et al. (2011). A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol 68:157–64.
  • Karavasili C, Andreadis DA, Katsamenis OL, et al. (2019). Synergistic antitumor potency of a self-assembling peptide hydrogel for the local co-delivery of doxorubicin and curcumin in the treatment of head and neck cancer. Mol Pharmaceutics 16:2326–41.
  • Komal K, Chaudhary S, Yadav P, et al. (2019). The therapeutic and preventive efficacy of curcumin and its derivatives in esophageal cancer. Asian Pac J Cancer Prev 20:1329–37.
  • Kunwar A, Barik A, Priyadarsini K, Pandey, R I. (2007). Absorption and fluorescence studies of curcumin bound to liposome and living cells. BARC Newsl 285:213–9.
  • Lanone S, Andujar P, Kermanizadeh A, Boczkowski J. (2013). Determinants of carbon nanotube toxicity. Adv Drug Deliv Rev 65:2063–9.
  • Lin S, Xie PL, Luo MM, et al. (2018). Efficiency against multidrug resistance by co-delivery of doxorubicin and curcumin with a legumain-sensitive nanocarrier. Nano Res 11:3619–35.
  • Li Y, Zhang T. (2014). Targeting cancer stem cells by curcumin and clinical applications. Cancer Lett 346:197–205.
  • Li HX, Zhang N, Hao YW, et al. (2014a). Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro. Drug Deliv 21:379–87.
  • Li HX, Zhang HL, Zhang N, et al. (2014b). Isolation of three curcuminoids for stability and simultaneous determination of only using one single standard substance in turmeric colour principles by HPLC with ternary gradient system. LWT-Food Sci Technol 57:446–51.
  • Malekmohammadi S, Hadadzadeh H, Farrokhpour H, Amirghofran Z. (2018). Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery. Soft Matter 14:2400–10.
  • Mohanty C, Sahoo SK. (2010). The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 31:6597–611.
  • Panda AK, Chakraborty D, Sarkar I, et al. (2017). New insights into therapeutic activity and anticancer properties of curcumin. J Exp Pharmacol 9:31–45.
  • Robinson JT, Welsher K, Tabakman SM, et al. (2010). High performance in vivo near-IR (>1 mum) imaging and photothermal cancer therapy with carbon nanotubes. Nano Res 3:779–93.
  • Saheb M, Fereydouni N, Nemati S, et al. (2019). Chitosan-based delivery systems for curcumin: a review of pharmacodynamic and pharmacokinetic aspects. J Cell Physiol 234:12325–40.
  • Sahne F, Mohammadi M, Najafpour GD. (2019). Single-layer assembly of multifunctional carboxymethylcellulose on graphene oxide nanoparticles for improving in vivo curcumin delivery into tumor cells. Acs Biomater Sci Eng 5:2595–609.
  • Shafabakhsh R, Pourhanifeh MH, Mirzaei HR, et al. (2019). Targeting regulatory T cells by curcumin: a potential for cancer immunotherapy. Pharmacol Res 147:104353.
  • Shahcheraghi SH, Zangui M, Lotfi M, et al. (2019). Therapeutic potential of curcumin in the treatment of glioblastoma multiforme. Curr Pharm Des 25:333–42.
  • Shi XQ, Wang Y, Sun HY, et al. (2019). Heparin-reduced graphene oxide nanocomposites for curcumin delivery: in vitro, in vivo and molecular dynamics simulation study. Biomater Sci 7:1011–27.
  • Singh N, Sachdev A, Gopinath P. (2018). Polysaccharide functionalized single walled carbon nanotubes as nanocarriers for delivery of curcumin in lung cancer cells. J Nanosci Nanotechnol 18:1534–41.
  • Tan BL, Norhaizan ME. (2019). Curcumin combination chemotherapy: the implication and efficacy in cancer. Molecules 24:2527.
  • Vallee A, Lecarpentier Y, Vallee JN. (2019). Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/beta-catenin pathway. J Exp Clin Cancer Res 38:323.
  • Wang M, Jiang S, Zhou L, et al. (2019). Potential mechanisms of action of curcumin for cancer prevention: focus on cellular signaling pathways and miRNAs. Int J Biol Sci 15:1200–14.
  • Willenbacher E, Khan SZ, Mujica SCA, et al. (2019). Curcumin: new insights into an ancient ingredient against cancer. Int J Mol Sci 20:1808.
  • Wong KE, Ngai SC, Chan KG, et al. (2019). Curcumin nanoformulations for colorectal cancer: a review. Front Pharmacol 10:152.
  • Yeung AWK, Horbańczuk M, Tzvetkov NT, et al. (2019). Curcumin: total-scale analysis of the scientific literature. Molecules 24:1393.
  • Yuan SP, Zeng LZ, Zhuang YY, et al. (2016). Functionalized single-walled carbon nanotubes for the improved solubilization and delivery of curcumin. Fuller Nanotub Car N 24:13–9.
  • Zheng BJ, Peng SF, Zhang XY, McClements DJ. (2018). Impact of delivery system type on curcumin bioaccessibility: comparison of curcumin-loaded nanoemulsions with commercial curcumin supplements. J Agric Food Chem 66:10816–26.